Romidepsin and interferon gamma: a novel combination for refractory cutaneous T-cell lymphoma

J Am Acad Dermatol. 2013 Jan;68(1):e5-6. doi: 10.1016/j.jaad.2011.06.043.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Depsipeptides / administration & dosage
  • Humans
  • Interferon-gamma / administration & dosage
  • Lymphoma, T-Cell, Cutaneous / drug therapy*
  • Male
  • Middle Aged
  • Skin Neoplasms / drug therapy*

Substances

  • Depsipeptides
  • Interferon-gamma
  • romidepsin